|
US7189834B2
(en)
*
|
1993-05-11 |
2007-03-13 |
Marshall William E |
Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
|
|
US20030109469A1
(en)
*
|
1993-08-26 |
2003-06-12 |
Carson Dennis A. |
Recombinant gene expression vectors and methods for use of same to enhance the immune response of a host to an antigen
|
|
US6727230B1
(en)
*
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US7935675B1
(en)
*
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
*
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US20030026782A1
(en)
*
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
|
US7422902B1
(en)
*
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
|
US5981501A
(en)
*
|
1995-06-07 |
1999-11-09 |
Inex Pharmaceuticals Corp. |
Methods for encapsulating plasmids in lipid bilayers
|
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
|
US6406705B1
(en)
*
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
JP4656675B2
(ja)
*
|
1997-05-14 |
2011-03-23 |
ユニバーシティー オブ ブリティッシュ コロンビア |
脂質小胞への荷電した治療剤の高率封入
|
|
AU760795B2
(en)
*
|
1998-05-14 |
2003-05-22 |
Coley Pharmaceutical Gmbh |
Methods for regulating hematopoiesis using CpG-oligonucleotides
|
|
JP2002516294A
(ja)
|
1998-05-22 |
2002-06-04 |
ローブ ヘルス リサーチ インスティチュート アット ザ オタワ ホスピタル |
粘膜免疫を誘導するための方法および産物
|
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
|
JP5084984B2
(ja)
|
1999-02-17 |
2012-11-28 |
シーエスエル、リミテッド |
免疫原複合体およびそれに関する方法
|
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
US20050002958A1
(en)
*
|
1999-06-29 |
2005-01-06 |
Smithkline Beecham Biologicals Sa |
Vaccines
|
|
WO2001012223A2
(en)
|
1999-08-19 |
2001-02-22 |
Dynavax Technologies Corporation |
Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
|
|
AU780979B2
(en)
*
|
1999-09-25 |
2005-04-28 |
Coley Pharmaceutical Gmbh |
Immunostimulatory nucleic acids
|
|
US6949520B1
(en)
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
|
DK1238070T3
(da)
*
|
1999-12-13 |
2007-12-03 |
Bioniche Life Sciences Inc |
Terapeutisk anvendelige syntetiske oligonucleotider
|
|
ATE378348T1
(de)
*
|
2000-01-14 |
2007-11-15 |
Us Health |
Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
|
|
EP1253947A4
(en)
|
2000-01-31 |
2005-01-05 |
Univ California |
IMMUNOMODULATORY POLYNUCLEOTIDES FOR THE TREATMENT OF INFECTION BY AN INTRACELLULAR PATHOGEN
|
|
US7585847B2
(en)
|
2000-02-03 |
2009-09-08 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for the treatment of asthma and allergy
|
|
AU4175101A
(en)
|
2000-02-23 |
2001-09-03 |
Univ California |
Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
|
|
US7129222B2
(en)
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
|
CA2405299C
(en)
|
2000-03-31 |
2014-07-22 |
Purdue Research Foundation |
Method of treatment using ligand-immunogen conjugates
|
|
SI1296713T1
(en)
|
2000-06-08 |
2004-02-29 |
Intercell Biomedizinische Forschungs- |
Immunostimulatory oligodeoxynucleotides
|
|
AU2001276831A1
(en)
|
2000-06-22 |
2002-01-02 |
Rxkinetix, Inc. |
Delivery vehicle composition and methods for delivering antigens and other drugs
|
|
PT1296714E
(pt)
|
2000-06-22 |
2009-10-15 |
Coley Pharm Gmbh |
Combinação de cpg e anticorpos dirigidos contra cd19, cd20, cd22 ou cd40 para o tratamento ou prevenção do cancro
|
|
KR100917101B1
(ko)
*
|
2000-08-04 |
2009-09-15 |
도요 보세키 가부시키가이샤 |
플렉시블 금속적층체 및 그 제조방법
|
|
US6943240B2
(en)
|
2000-09-15 |
2005-09-13 |
Coley Pharmaceuticals Gmbh |
Nucleic acids for high throughput screening of CpG-based immuno-agonist/antagonist
|
|
AU2001297693A1
(en)
*
|
2000-12-08 |
2002-09-12 |
Coley Pharmaceutical Gmbh |
Cpg-like nucleic acids and methods of use thereof
|
|
ES2347525T3
(es)
|
2000-12-27 |
2010-11-02 |
Dynavax Technologies Corporation |
Polinucleotidos inmunomoduladores y metodos para usuarios.
|
|
US7785610B2
(en)
*
|
2001-06-21 |
2010-08-31 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same—III
|
|
US20040132677A1
(en)
*
|
2001-06-21 |
2004-07-08 |
Fearon Karen L. |
Chimeric immunomodulatory compounds and methods of using the same-IV
|
|
DK2423335T3
(da)
|
2001-06-21 |
2014-08-18 |
Dynavax Tech Corp |
Kimæriske immunmodulatoriske forbindelser og fremgangsmåder til anvendelse deraf
|
|
AU2002322358B2
(en)
*
|
2001-06-29 |
2009-06-18 |
Novartis Vaccines And Diagnostics, Inc. |
HCV E1E2 vaccine compositions
|
|
US7666674B2
(en)
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
|
CA2456328C
(en)
|
2001-08-07 |
2015-05-26 |
Dynavax Technologies Corporation |
Complexes of a short cpg-containing oligonucleotide bound to the surface of a solid phase microcarrier and methods for use thereof
|
|
US7354909B2
(en)
*
|
2001-08-14 |
2008-04-08 |
The United States Of America As Represented By Secretary Of The Department Of Health And Human Services |
Method for rapid generation of mature dendritic cells
|
|
MXPA04001458A
(es)
*
|
2001-08-17 |
2005-02-17 |
Univ Iowa Res Found |
Oligonucleotidos inmunoestimuladores de motivos combinados con actividad mejorada.
|
|
AU2008200016B2
(en)
*
|
2001-08-17 |
2012-04-19 |
Coley Pharmaceutical Gmbh |
Combination motif immune stimulatory oligonucleotides with improved activity
|
|
JP2005501917A
(ja)
|
2001-09-07 |
2005-01-20 |
ザ トラスティーズ オブ ボストン ユニバーシティ |
免疫複合体関連疾患を処置するための方法および組成物
|
|
DE60234375D1
(de)
*
|
2001-09-14 |
2009-12-24 |
Cytos Biotechnology Ag |
VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
|
|
EP1434603B1
(en)
*
|
2001-09-28 |
2009-12-16 |
Purdue Research Foundation |
Method of treatment using ligand-immunogen conjugates
|
|
AU2002346960A1
(en)
|
2001-10-06 |
2003-04-22 |
Merial Limited |
Methods and compositions for promoting growth and innate immunity in young animals
|
|
US20030139364A1
(en)
*
|
2001-10-12 |
2003-07-24 |
University Of Iowa Research Foundation |
Methods and products for enhancing immune responses using imidazoquinoline compounds
|
|
US7276489B2
(en)
*
|
2002-10-24 |
2007-10-02 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
|
|
JP2005516897A
(ja)
*
|
2001-11-07 |
2005-06-09 |
イネックス ファーマシューティカルズ コーポレイション |
改善された粘膜のワクチン及びその使用方法
|
|
US8466116B2
(en)
|
2001-12-20 |
2013-06-18 |
The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of CpG oligodeoxynucleotides to induce epithelial cell growth
|
|
US7615227B2
(en)
*
|
2001-12-20 |
2009-11-10 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of CpG oligodeoxynucleotides to induce angiogenesis
|
|
EP1467755A1
(en)
|
2001-12-21 |
2004-10-20 |
Antigenics Inc. |
Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
|
|
US8088388B2
(en)
*
|
2002-02-14 |
2012-01-03 |
United Biomedical, Inc. |
Stabilized synthetic immunogen delivery system
|
|
EP1499187B1
(en)
|
2002-04-04 |
2015-06-17 |
Zoetis Belgium S.A. |
Immunostimulatory g,u-containing oligoribonucleotides
|
|
US7371734B2
(en)
*
|
2002-04-22 |
2008-05-13 |
Bioniche Life Sciences Inc. |
Oligonucleotide compositions and their use for the modulation of immune responses
|
|
US20040013649A1
(en)
*
|
2002-05-10 |
2004-01-22 |
Inex Pharmaceuticals Corporation |
Cancer vaccines and methods of using the same
|
|
US20040009944A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Methylated immunostimulatory oligonucleotides and methods of using the same
|
|
US20040009943A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Pathogen vaccines and methods for using the same
|
|
KR100456681B1
(ko)
*
|
2002-05-22 |
2004-11-10 |
주식회사 대웅 |
박테리아의 염색체 ｄｎａ 파쇄물과 비독성리포폴리사카라이드를 포함하는 면역강화 및 조절 조성물
|
|
CA2388049A1
(en)
|
2002-05-30 |
2003-11-30 |
Immunotech S.A. |
Immunostimulatory oligonucleotides and uses thereof
|
|
CN1662253A
(zh)
*
|
2002-06-20 |
2005-08-31 |
赛托斯生物技术公司 |
用作佐剂的包装的病毒样颗粒:制备方法与用途
|
|
EP1539215A2
(en)
*
|
2002-06-25 |
2005-06-15 |
City of Hope |
Adjuvant-free peptide vaccine
|
|
US7569553B2
(en)
|
2002-07-03 |
2009-08-04 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US7807803B2
(en)
|
2002-07-03 |
2010-10-05 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US7605138B2
(en)
|
2002-07-03 |
2009-10-20 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US20040053880A1
(en)
*
|
2002-07-03 |
2004-03-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US7576066B2
(en)
|
2002-07-03 |
2009-08-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
AU2003247880B2
(en)
*
|
2002-07-03 |
2010-09-02 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
SG166673A1
(en)
*
|
2002-08-19 |
2010-12-29 |
Coley Pharm Group Inc |
Immunostimulatory nucleic acids
|
|
AR040996A1
(es)
|
2002-08-19 |
2005-04-27 |
Coley Pharm Group Inc |
Acidos nucleicos inmunoestimuladores
|
|
WO2004024919A1
(en)
*
|
2002-09-13 |
2004-03-25 |
Replicor, Inc. |
Non-sequence complementary antiviral oligonucleotides
|
|
US8263091B2
(en)
|
2002-09-18 |
2012-09-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
|
|
CN101948835A
(zh)
|
2002-10-29 |
2011-01-19 |
科勒制药集团股份有限公司 |
Cpg寡核苷酸在治疗丙型肝炎病毒感染中的应用
|
|
US7758876B2
(en)
*
|
2002-11-01 |
2010-07-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides
|
|
JP2006512927A
(ja)
|
2002-12-11 |
2006-04-20 |
コーリー ファーマシューティカル グループ，インコーポレイテッド |
５’ｃｐｇ核酸およびその使用方法
|
|
TW201139672A
(en)
|
2002-12-13 |
2011-11-16 |
Novartis Ag |
Immunization of fish with plant-expressed recombinant proteins
|
|
EP1575977B1
(en)
|
2002-12-23 |
2009-09-09 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
|
AU2003302743B2
(en)
|
2002-12-23 |
2008-09-04 |
Dynavax Technologies Corporation |
Branched immunomodulatory compounds and methods of using the same
|
|
US8158768B2
(en)
|
2002-12-23 |
2012-04-17 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
|
AU2004213855B2
(en)
|
2003-02-20 |
2010-03-04 |
University Of Connecticut Health Center |
Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
|
|
US7537767B2
(en)
|
2003-03-26 |
2009-05-26 |
Cytis Biotechnology Ag |
Melan-A- carrier conjugates
|
|
WO2004085635A1
(en)
*
|
2003-03-26 |
2004-10-07 |
Cytos Biotechnology Ag |
Melan-a peptide analogue-virus-like-particle conjugates
|
|
EP1608403A2
(en)
*
|
2003-04-02 |
2005-12-28 |
Coley Pharmaceutical Group, Ltd. |
Immunostimulatory nucleic acid oil-in-water formulations for topical application
|
|
AU2004229446B2
(en)
*
|
2003-04-09 |
2010-02-25 |
Bgp Products Operations Gmbh |
Aerosolization apparatus with air inlet shield
|
|
AU2004238139B2
(en)
*
|
2003-05-15 |
2009-12-03 |
Japan Science And Technology Agency |
Immunostimulating Agents
|
|
JP2007524615A
(ja)
|
2003-06-20 |
2007-08-30 |
コーリー ファーマシューティカル ゲーエムベーハー |
低分子トール様レセプター（ｔｌｒ）アンタゴニスト
|
|
CN100404070C
(zh)
|
2003-07-10 |
2008-07-23 |
赛托斯生物技术公司 |
包装的病毒样颗粒
|
|
CN103446582A
(zh)
*
|
2003-08-11 |
2013-12-18 |
财团法人阪大微生物病研究会 |
包含诱导粘膜免疫的佐剂的新型疫苗
|
|
JP4926707B2
(ja)
|
2003-08-22 |
2012-05-09 |
ダニスコ エイ／エス |
封入化抗菌材料
|
|
GB2388581A
(en)
|
2003-08-22 |
2003-11-19 |
Danisco |
Coated aqueous beads
|
|
JP2007505147A
(ja)
|
2003-09-12 |
2007-03-08 |
アンティジェニクス インコーポレーテッド |
単純ヘルペスウイルス感染の治療および予防用ワクチン
|
|
US7615539B2
(en)
|
2003-09-25 |
2009-11-10 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid-lipophilic conjugates
|
|
CA2542099A1
(en)
*
|
2003-10-11 |
2005-04-21 |
Inex Pharmaceuticals Corporation |
Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity
|
|
US8188254B2
(en)
|
2003-10-30 |
2012-05-29 |
Coley Pharmaceutical Gmbh |
C-class oligonucleotide analogs with enhanced immunostimulatory potency
|
|
US20050239733A1
(en)
*
|
2003-10-31 |
2005-10-27 |
Coley Pharmaceutical Gmbh |
Sequence requirements for inhibitory oligonucleotides
|
|
US20050100983A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Coley Pharmaceutical Gmbh |
Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLR9) signaling
|
|
AU2004304770B2
(en)
*
|
2003-12-08 |
2010-05-06 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties by small oligonucleotide-based compounds
|
|
DE10361502A1
(de)
*
|
2003-12-23 |
2005-07-28 |
Phenion Gmbh & Co. Kg |
Kosmetische oder pharmazeutische Zubereitungen enthaltend Superstruktur-bildende Nukleinsäure-Sequenzen
|
|
KR100558851B1
(ko)
*
|
2004-01-08 |
2006-03-10 |
학교법인연세대학교 |
면역조절능력이 증가된 ＣｐＧ 올리고데옥시뉴클레오티드변형체
|
|
WO2005072290A2
(en)
*
|
2004-01-23 |
2005-08-11 |
Joslin Diabetes Center |
Methods of treating, reducing, or preventing autoimmune conditions
|
|
WO2005097993A2
(en)
*
|
2004-02-19 |
2005-10-20 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory viral rna oligonucleotides
|
|
WO2005111057A2
(en)
*
|
2004-04-02 |
2005-11-24 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for inducing il-10 responses
|
|
JP2008501807A
(ja)
*
|
2004-06-08 |
2008-01-24 |
コーリー ファーマシューティカル ゲーエムベーハー |
抗原ならびに免疫活性化アゴニストおよび免疫活性化アンタゴニストのための担体基本骨格としての無塩基オリゴヌクレオチド
|
|
US7674456B2
(en)
*
|
2004-06-14 |
2010-03-09 |
Charles Wiseman |
Breast cancer cell lines and uses thereof
|
|
AU2005335104C1
(en)
|
2004-07-18 |
2010-10-28 |
Csl Limited |
Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses
|
|
CA2575490A1
(en)
|
2004-08-03 |
2006-02-16 |
Frank Notka |
Method for modulating gene expression by altering the cpg content
|
|
EP2305693B1
(en)
|
2004-09-01 |
2015-07-15 |
Dynavax Technologies Corporation |
Methods and compositions for inhibition of innate immune responses and autoimmunity
|
|
MY159370A
(en)
|
2004-10-20 |
2016-12-30 |
Coley Pharm Group Inc |
Semi-soft-class immunostimulatory oligonucleotides
|
|
EP1657307A1
(en)
*
|
2004-11-16 |
2006-05-17 |
Immunotech S.A. |
Oligonucleotides that induce the secretion of GM-CSF
|
|
AU2006216493A1
(en)
*
|
2005-02-24 |
2006-08-31 |
Coley Pharmaceutical Gmbh |
Immunostimulatory oligonucleotides
|
|
JP5403457B2
(ja)
*
|
2005-02-28 |
2014-01-29 |
株式会社明治 |
Ａｔオリゴヌクレオチドを有効成分とする免疫応答増強性薬剤及び食品組成物
|
|
WO2006096497A2
(en)
|
2005-03-04 |
2006-09-14 |
Dynavax Technologies Corporation |
Vaccines comprising oligonucleotides having immunostimulatory sequences (iss) wherein the iss are conjugated to antigens and stabilized by buffer conditions and further excipients
|
|
RU2414239C2
(ru)
|
2005-03-18 |
2011-03-20 |
Цитос Биотехнологи Аг |
Белки, слитые с кошачьим аллергеном, и их применение
|
|
CN101193646A
(zh)
*
|
2005-04-08 |
2008-06-04 |
科勒制药集团公司 |
治疗传染病加剧性哮喘的方法
|
|
WO2006110655A2
(en)
|
2005-04-08 |
2006-10-19 |
Chimerix, Inc. |
Compounds, compositions and methods for the treatment of poxvirus infections
|
|
EP1877037A2
(en)
|
2005-04-28 |
2008-01-16 |
Novo Nordisk Health Care AG |
A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit
|
|
DE102005022290A1
(de)
*
|
2005-05-13 |
2006-11-16 |
Universitätsklinikum Schleswig-Holstein |
Hexanukleotid-Wirkstoffe
|
|
CN1865275B
(zh)
*
|
2005-05-17 |
2011-06-15 |
长春华普生物技术有限公司 |
对人b细胞肿瘤有治疗作用的人工合成的单链脱氧核苷酸
|
|
EP2380584B1
(en)
|
2005-07-01 |
2013-10-16 |
Index Pharmaceuticals AB |
Immunostimulatory method
|
|
DK2179737T3
(da)
|
2005-07-01 |
2013-11-11 |
Index Pharmaceuticals Ab |
Modulering af respons på steroider
|
|
MX2008000379A
(es)
*
|
2005-07-07 |
2008-03-18 |
Coley Pharm Group Inc |
Anticuerpo anti-citla-1 y terapia de combinacio con oligodesoxinucleotido sintetico que contiene motivo cpg.
|
|
CA2622679A1
(en)
*
|
2005-09-16 |
2007-08-09 |
Coley Pharmaceutical Gmbh |
Immunostimulatory single-stranded ribonucleic acid with phosphodiester backbone
|
|
KR20080047463A
(ko)
*
|
2005-09-16 |
2008-05-28 |
콜리 파마슈티칼 게엠베하 |
뉴클레오티드 변형에 의한 짧은 간섭 리보핵산(ｓｉｒｎａ)의 면역자극 특성의 조절
|
|
AU2006306805A1
(en)
|
2005-10-28 |
2007-05-03 |
Index Pharmaceuticals Ab |
Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease
|
|
MX2008005640A
(es)
*
|
2005-11-02 |
2008-12-09 |
Univ Duke |
Quimioterapia e inmunoterapia concurrentes.
|
|
CN102755645A
(zh)
|
2005-11-04 |
2012-10-31 |
诺华疫苗和诊断有限公司 |
佐剂配制的包含细胞因子诱导剂的流感疫苗
|
|
ES2420829T3
(es)
|
2005-11-04 |
2013-08-27 |
Novartis Vaccines And Diagnostics S.R.L. |
Vacunas adyuvantadas con antígeno de no virión preparadas a partir de virus de la gripe cultivados en cultivo celular
|
|
EP1951299B1
(en)
|
2005-11-04 |
2012-01-04 |
Novartis Vaccines and Diagnostics S.r.l. |
Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
|
|
EP1951302A2
(en)
|
2005-11-04 |
2008-08-06 |
Novartis Vaccines and Diagnostics S.r.l. |
Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
|
|
CN102864152B
(zh)
*
|
2005-11-07 |
2015-11-18 |
艾德拉药物股份有限公司 |
包含经修饰的免疫刺激性二核苷酸的基于寡核苷酸的化合物之免疫刺激特性
|
|
JP4538522B2
(ja)
|
2005-11-25 |
2010-09-08 |
コーリー ファーマシューティカル ゲーエムベーハー |
免疫刺激性オリゴリボヌクレオチド
|
|
NZ569741A
(en)
|
2005-12-14 |
2012-02-24 |
Cytos Biotechnology Ag |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
|
KR20080089663A
(ko)
|
2006-01-27 |
2008-10-07 |
노바티스 백신즈 앤드 다이아그노스틱스 게엠베하 운트 콤파니 카게 |
적혈구응집소 및 기질 단백질을 함유한 인플루엔자 백신
|
|
MX2008009970A
(es)
*
|
2006-02-01 |
2008-11-19 |
Univ Johns Hopkins |
Conjugados de polipeptido-acido nucleico para inmunoprofilaxis o inmunoterapia para desordenes neoplasicos o infecciosos.
|
|
US8168164B2
(en)
|
2006-02-03 |
2012-05-01 |
Purdue Research Foundation |
Targeted conjugates and radiation
|
|
ES2526879T3
(es)
*
|
2006-02-15 |
2015-01-16 |
Adiutide Pharmaceuticals Gmbh |
Composiciones y procedimientos para formulaciones de oligonucleótidos
|
|
CN100418583C
(zh)
*
|
2006-02-21 |
2008-09-17 |
朱鸿飞 |
预防和治疗乳腺炎的药物组合物
|
|
JP2009534303A
(ja)
|
2006-03-24 |
2009-09-24 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー |
冷蔵しないインフルエンザワクチンの保存
|
|
US9107863B2
(en)
*
|
2006-03-27 |
2015-08-18 |
The Buck Institute For Age Reasearch |
Reagents and methods for cancer treatment and prevention
|
|
US20100285062A1
(en)
|
2006-03-31 |
2010-11-11 |
Novartis Ag |
Combined mucosal and parenteral immunization against hiv
|
|
WO2007131237A2
(en)
|
2006-05-05 |
2007-11-15 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for modulating expression of ptp1b
|
|
RU2464030C2
(ru)
*
|
2006-05-26 |
2012-10-20 |
Регадо Байосайенсиз, Инк. |
Введение противосвертывающей системы reg1
|
|
US20110206692A1
(en)
|
2006-06-09 |
2011-08-25 |
Novartis Ag |
Conformers of bacterial adhesins
|
|
EP2032592B1
(en)
|
2006-06-12 |
2013-07-31 |
Cytos Biotechnology AG |
Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages
|
|
US20100129403A1
(en)
|
2006-06-20 |
2010-05-27 |
Transgene S.A. |
Recombinant viral vaccine
|
|
GB0614460D0
(en)
|
2006-07-20 |
2006-08-30 |
Novartis Ag |
Vaccines
|
|
WO2008032219A2
(en)
|
2006-09-11 |
2008-03-20 |
Novartis Ag |
Making influenza virus vaccines without using eggs
|
|
NZ575437A
(en)
|
2006-09-27 |
2012-02-24 |
Coley Pharm Gmbh |
Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
|
|
WO2008057529A2
(en)
*
|
2006-11-06 |
2008-05-15 |
Coley Pharmaceutical Group, Inc. |
Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp)
|
|
PL2121011T3
(pl)
|
2006-12-06 |
2014-10-31 |
Novartis Ag |
Szczepionki zawierające antygeny czterech szczepów wirusa grypy
|
|
UA100370C2
(uk)
|
2006-12-11 |
2012-12-25 |
Мериал Лимитед |
Спосіб вакцинації птахів проти salmonella
|
|
CN101611048B
(zh)
|
2006-12-12 |
2012-11-07 |
赛托斯生物技术公司 |
含有高浓度鸟嘌呤单体的寡核苷酸
|
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
|
PT2185191E
(pt)
|
2007-06-27 |
2012-11-27 |
Novartis Ag |
Vacinas contra a gripe com baixo teor de aditivos
|
|
EP2178896A1
(en)
*
|
2007-07-31 |
2010-04-28 |
The Johns Hopkins University |
Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
|
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
|
JP5749492B2
(ja)
|
2007-10-26 |
2015-07-15 |
ダイナバックス テクノロジーズ コーポレイション |
免疫応答と自己免疫を阻害する方法及び組成物
|
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
|
GB0818453D0
(en)
|
2008-10-08 |
2008-11-12 |
Novartis Ag |
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
|
|
MX2010008148A
(es)
|
2008-01-25 |
2010-10-20 |
Chimerix Inc |
Métodos de tratamiento de infecciones virales.
|
|
ES2535101T3
(es)
|
2008-03-18 |
2015-05-05 |
Novartis Ag |
Mejoras en la preparación de antígenos en vacuna de virus de la gripe
|
|
CN103768588A
(zh)
|
2008-05-08 |
2014-05-07 |
梅里亚有限公司 |
使用白蛉唾液免疫原的利什曼原虫疫苗
|
|
TWI351288B
(en)
*
|
2008-07-04 |
2011-11-01 |
Univ Nat Pingtung Sci & Tech |
Cpg dna adjuvant in avian vaccines
|
|
ES2616051T3
(es)
|
2008-12-02 |
2017-06-09 |
Wave Life Sciences Japan, Inc. |
Método para la síntesis de ácidos nucleicos modificados en el átomo de fósforo
|
|
CN102361985B
(zh)
*
|
2008-12-04 |
2017-06-20 |
库尔纳公司 |
通过抑制肿瘤抑制基因的天然反义转录物治疗肿瘤抑制基因相关性疾病
|
|
US8552165B2
(en)
*
|
2008-12-09 |
2013-10-08 |
Heather Davis |
Immunostimulatory oligonucleotides
|
|
NZ593220A
(en)
|
2008-12-09 |
2012-10-26 |
Coley Pharm Group Inc |
Immunostimulatory oligonucleotides
|
|
HUE026280T2
(en)
*
|
2009-02-12 |
2016-06-28 |
Curna Inc |
Treatment of brain-derived neurotrophic factor (BDNF) -related diseases by inhibition of natural antisense transcripts associated with BDNF \ t
|
|
ES2658626T3
(es)
*
|
2009-02-12 |
2018-03-12 |
Curna, Inc. |
Tratamiento de enfermedades relacionadas con el factor neurotrófico derivado de células gliales (GDNF) por inhibición de transcrito antisentido natural a GDNF
|
|
CN102438650A
(zh)
|
2009-03-06 |
2012-05-02 |
诺华有限公司 |
衣原体抗原
|
|
PT2411521E
(pt)
|
2009-03-25 |
2015-04-21 |
Univ Texas |
Composições para estimulação de resistência imunitária inata de mamíferos contra patogénicos
|
|
AU2010232490B2
(en)
|
2009-04-03 |
2016-08-11 |
Agenus Inc. |
Methods for preparing and using multichaperone-antigen complexes
|
|
HUE028803T2
(en)
|
2009-04-14 |
2017-01-30 |
Glaxosmithkline Biologicals Sa |
Preparations for immunization against Staphylococcus aureus
|
|
USH2283H1
(en)
|
2009-04-27 |
2013-09-03 |
Novartis Ag |
Vaccines for protecting against influenza
|
|
EP2451461A4
(en)
|
2009-07-06 |
2013-05-29 |
Ontorii Inc |
NOVEL NUCLEIC ACID PRODRUGS AND METHOD OF USE THEREOF
|
|
SG177533A1
(en)
|
2009-07-07 |
2012-02-28 |
Novartis Ag |
Conserved escherichia coli immunogens
|
|
TW201116294A
(en)
|
2009-07-15 |
2011-05-16 |
Novartis Ag |
RSV F protein compositions and methods for making same
|
|
CN102770443A
(zh)
|
2009-07-16 |
2012-11-07 |
诺华有限公司 |
脱毒大肠杆菌免疫原
|
|
CA2768947C
(en)
*
|
2009-07-24 |
2018-06-19 |
Opko Curna, Llc |
Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
|
|
US20120295952A1
(en)
*
|
2009-09-25 |
2012-11-22 |
Curna, Inc. |
Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
|
|
GB0918392D0
(en)
|
2009-10-20 |
2009-12-02 |
Novartis Ag |
Diagnostic and therapeutic methods
|
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
|
EP2501800A4
(en)
|
2009-11-17 |
2013-05-22 |
Musc Found For Res Dev |
HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN NUCLEOLIN
|
|
US9683242B2
(en)
|
2009-11-23 |
2017-06-20 |
M.S. Technologies, Llc |
Herbicide tolerant soybean plants and methods for identifying same
|
|
AU2010321584C1
(en)
|
2009-11-23 |
2016-12-22 |
BASF Agricultural Solutions Seed US LLC |
Elite event EE-GM3 and methods and kits for identifying such event in biological samples
|
|
JP5781542B2
(ja)
|
2009-12-30 |
2015-09-24 |
ノバルティス アーゲー |
Ｅ．ｃｏｌｉキャリアタンパク質に結合体化した多糖免疫原
|
|
EP3216789A1
(en)
|
2010-02-12 |
2017-09-13 |
Chimerix, Inc. |
Methods of treating viral infection
|
|
WO2011139709A2
(en)
|
2010-04-26 |
2011-11-10 |
Chimerix, Inc. |
Methods of treating retroviral infections and related dosage regimes
|
|
WO2011150240A1
(en)
|
2010-05-26 |
2011-12-01 |
Selecta Biosciences, Inc. |
Nanocarrier compositions with uncoupled adjuvant
|
|
GB201009861D0
(en)
|
2010-06-11 |
2010-07-21 |
Novartis Ag |
OMV vaccines
|
|
CA2802873C
(en)
|
2010-06-16 |
2018-09-18 |
Dynavax Technologies Corporation |
Methods of treatment using tlr7 and/or tlr9 inhibitors
|
|
CN103025873B
(zh)
*
|
2010-06-23 |
2018-05-08 |
库尔纳公司 |
通过抑制电压门控钠通道α亚基(SCNA)的天然反义转录物而治疗SCNA相关疾病
|
|
MX2013000164A
(es)
*
|
2010-07-06 |
2013-03-05 |
Novartis Ag |
Liposomas con lipidos que tienen valor de pka ventajoso para suministro de arn.
|
|
JP5868324B2
(ja)
|
2010-09-24 |
2016-02-24 |
株式会社Ｗａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｊａｐａｎ |
不斉補助基
|
|
US9994443B2
(en)
|
2010-11-05 |
2018-06-12 |
Selecta Biosciences, Inc. |
Modified nicotinic compounds and related methods
|
|
TR201908715T4
(tr)
|
2011-01-26 |
2019-07-22 |
Glaxosmithkline Biologicals Sa |
Rsv immünizasyon rejimi.
|
|
WO2012142480A1
(en)
*
|
2011-04-14 |
2012-10-18 |
Beth Israel Deaconess Medical Center, Inc. |
Chimeric rna oligonucleotides and uses thereof
|
|
EP2707385B1
(en)
|
2011-05-13 |
2017-09-20 |
GlaxoSmithKline Biologicals SA |
Pre-fusion rsv f antigens
|
|
TWI692485B
(zh)
|
2011-05-20 |
2020-05-01 |
美商艾爾德生物控股有限責任公司 |
抗降血鈣素基因相關胜肽（ａｎｔｉ-ｃｇｒｐ）組成物及其用途
|
|
EP2709663B1
(en)
|
2011-05-20 |
2019-03-20 |
AlderBio Holdings LLC |
Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
|
|
CN108359008B
(zh)
|
2011-05-20 |
2022-03-29 |
H.伦德贝克公司 |
抗cgrp或抗cgrp-r抗体或抗体片段用于治疗或预防慢性和急性形式的腹泻的用途
|
|
EP2729124B1
(en)
*
|
2011-07-06 |
2018-10-24 |
GlaxoSmithKline Biologicals SA |
Cationic oil-in-water emulsions
|
|
EP2729178A1
(en)
|
2011-07-08 |
2014-05-14 |
Novartis AG |
Tyrosine ligation process
|
|
EP2729180B1
(en)
|
2011-07-08 |
2019-01-23 |
The University of North Carolina At Chapel Hill |
Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
|
|
US9605019B2
(en)
|
2011-07-19 |
2017-03-28 |
Wave Life Sciences Ltd. |
Methods for the synthesis of functionalized nucleic acids
|
|
PT2734230T
(pt)
|
2011-07-20 |
2019-02-27 |
Roussy Inst Gustave |
Vacina recombinante contra o vírus da leucemia felina contendo um gene de envelope do vírus da leucemia felina otimizado
|
|
BR112014002139A2
(pt)
|
2011-07-29 |
2017-02-21 |
Selecta Biosciences Inc |
nanotransportadores sintéticos que geram respostas imunes humorais e de linfócitos t citotóxicos (ctl)
|
|
AU2012335208B2
(en)
|
2011-11-07 |
2017-08-31 |
Glaxosmithkline Biologicals S.A. |
Carrier molecule comprising a spr0096 and a spr2021 antigen
|
|
JP6155533B2
(ja)
*
|
2012-02-28 |
2017-07-05 |
国立大学法人東京農工大学 |
Ｔｄｐ−４３細胞内存在量関連疾患の認定方法
|
|
AU2013235423B2
(en)
|
2012-03-20 |
2017-03-30 |
Boehringer Ingelheim Animal Health USA Inc. |
Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof
|
|
JP2014012650A
(ja)
*
|
2012-07-05 |
2014-01-23 |
Nihon Univ |
上皮バリア機能の増強方法及び増強剤
|
|
SG10201912895PA
(en)
|
2012-07-13 |
2020-02-27 |
Wave Life Sciences Ltd |
Chiral control
|
|
BR112015000723A2
(pt)
*
|
2012-07-13 |
2017-06-27 |
Shin Nippon Biomedical Laboratories Ltd |
adjuvante de ácido nucléico quiral
|
|
RU2693381C2
(ru)
|
2012-07-13 |
2019-07-02 |
Уэйв Лайф Сайенсес Лтд. |
Асимметричная вспомогательная группа
|
|
NZ705790A
(en)
|
2012-08-30 |
2016-06-24 |
Top Ind S A S |
Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins
|
|
SG11201502197XA
(en)
|
2012-10-02 |
2015-04-29 |
Glaxosmithkline Biolog Sa |
Nonlinear saccharide conjugates
|
|
JP6340011B2
(ja)
|
2012-11-30 |
2018-06-06 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
シュードモナス抗原および抗原の組み合わせ
|
|
AU2014220668B2
(en)
|
2013-02-20 |
2018-12-13 |
Innate Pharma |
A compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma
|
|
US9427647B2
(en)
*
|
2013-04-26 |
2016-08-30 |
Russell I. Moy |
Climbing hold assembly having load dissipative effect
|
|
US20160130346A1
(en)
*
|
2013-05-29 |
2016-05-12 |
Institut National De La Sante Et De La Recherche Medicale |
Kir3dl2 is a biomarker and a therapeutic target useful for respectively preventing and treating a subset of cutaneous and non-cutaneous peripheral t-cell lymphomas
|
|
WO2014201245A1
(en)
|
2013-06-12 |
2014-12-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Tlr-9 agonist with tlr-7 and/or tlr-8 agonist for treating tumors
|
|
US20170114122A1
(en)
|
2015-10-23 |
2017-04-27 |
Alderbio Holdings Llc |
Regulation of glucose metabolism using anti-cgrp antibodies
|
|
ES2750608T3
(es)
|
2013-07-25 |
2020-03-26 |
Exicure Inc |
Construcciones esféricas a base de ácido nucleico como agentes inmunoestimulantes para uso profiláctico y terapéutico
|
|
EP2870974A1
(en)
|
2013-11-08 |
2015-05-13 |
Novartis AG |
Salmonella conjugate vaccines
|
|
US10144933B2
(en)
|
2014-01-15 |
2018-12-04 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
|
|
US10322173B2
(en)
|
2014-01-15 |
2019-06-18 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
|
EP3095459A4
(en)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having antitumor effect and antitumor agent
|
|
CA2936712A1
(en)
|
2014-01-16 |
2015-07-23 |
Meena |
Chiral design
|
|
CA2953216C
(en)
|
2014-06-04 |
2020-12-22 |
Exicure, Inc. |
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
|
|
US10286065B2
(en)
|
2014-09-19 |
2019-05-14 |
Board Of Regents, The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
|
AU2015349680A1
(en)
|
2014-11-21 |
2017-06-08 |
Northwestern University |
The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
|
|
EA201792501A1
(ru)
|
2015-05-13 |
2018-10-31 |
Эйдженус Инк. |
Вакцины для лечения и профилактики рака
|
|
WO2016207853A2
(en)
|
2015-06-26 |
2016-12-29 |
Seqirus UK Limited |
Antigenically matched influenza vaccines
|
|
CN114807152A
(zh)
|
2016-06-08 |
2022-07-29 |
哈佛学院院长及董事 |
工程化病毒载体减少了炎症和免疫反应的诱导
|
|
CN109689095B
(zh)
*
|
2016-07-26 |
2023-10-03 |
拜耳动物保健有限责任公司 |
牛物种中增加的生育力
|
|
WO2018039629A2
(en)
|
2016-08-25 |
2018-03-01 |
Northwestern University |
Micellar spherical nucleic acids from thermoresponsive, traceless templates
|
|
US11696954B2
(en)
|
2017-04-28 |
2023-07-11 |
Exicure Operating Company |
Synthesis of spherical nucleic acids using lipophilic moieties
|
|
US11433131B2
(en)
|
2017-05-11 |
2022-09-06 |
Northwestern University |
Adoptive cell therapy using spherical nucleic acids (SNAs)
|
|
WO2019028250A1
(en)
|
2017-08-02 |
2019-02-07 |
The University Of Chicago |
NOMOGENEOUS ORGANOMETALLIC ORGANOMETRIC ORGANOMETRIC LAYERS FOR X-RAY INDUCED PHOTODYNAMIC THERAPY, RADIOTHERAPY, RODIODYNAMIC THERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF
|
|
KR20200085812A
(ko)
|
2017-11-08 |
2020-07-15 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
바이러스 벡터-유도된 염증 반응을 억제하기 위한 조성물 및 방법
|
|
JP7458977B2
(ja)
*
|
2017-12-15 |
2024-04-01 |
エランコ アニマル ヘルス ゲー・エム・ベー・ハー |
免疫刺激性組成物
|
|
CA3123237A1
(en)
|
2019-01-08 |
2020-07-16 |
H. Lundbeck A/S |
Acute treatment and rapid treatment of headache using anti-cgrp antibodies
|
|
AU2020400234A1
(en)
*
|
2019-12-13 |
2022-07-07 |
Grand Theravac Life Science (Nanjing) Co., Ltd. |
Pharmaceutical composition and use thereof
|
|
US20230241196A1
(en)
|
2020-01-27 |
2023-08-03 |
Oregon State University |
Gonorrhea subunit vaccine
|
|
CN114181888B
(zh)
*
|
2021-11-24 |
2023-12-08 |
汕头大学 |
一种浅色黄姑鱼鱼鳔细胞系的建立方法及应用
|
|
CN115252603A
(zh)
*
|
2022-07-08 |
2022-11-01 |
深圳市第二人民医院(深圳市转化医学研究院) |
indisulam在制备治疗膀胱癌的药物中的应用
|